FDA inspectors arrive at the manufacturing facility for re-inspection. They remain till May 1. Late that afternoon, word comes from Washington that Burzynski may once again accept new patients. For the patient in the hospital who is now close to death, it comes too late. Many of the comments concern a clinical trial of rare brain tumors in children such as rhabdoid tumor of the brain, the most aggressive of all childhood cancers.
Conventional therapy is useless against it.
Burzynski is currently treating two children suffering from rhabdoid brain tumors. Dr. Burzynski has evidence of success against this type of tumor. More documentation is available from BRI detailing the struggle. A nationally-renowned cameraman, has put together a videotape chronicling patients' struggle with FDA for the right to treatment of their choice. Ralph W. Moss, Ph.D. is director of the The Moss Reports for cancer patients.